A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2002
12/27/2002	WO2002085409A3 Methods and compositions for inducing an immune response to an antigen
12/27/2002	WO2002072852A3 Leporipox-based vector vaccines
12/27/2002	WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002	WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002	WO2002056831A9 Immunogenic proteoliposomes, and uses thereof
12/27/2002	WO2002051994A3 Polypeptides
12/27/2002	WO2002045746A3 Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
12/27/2002	WO2002040515A3 Exoenzyme toxin of aeromonas salmonicida, and uses thereof
12/27/2002	WO2002040514A3 Type iii secretion pathway in aeromonas salmonicida, and uses therefor
12/27/2002	WO2002038733B1 A selectable genetic marker for use in pasteurellaceae species
12/27/2002	WO2002036750A3 T-cells specifically recognizing minor histocompatibility antigen(s) and uses thereof for eliminating target cells
12/27/2002	WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002	WO2002016593A3 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
12/27/2002	WO2002012467A3 Drug metabolizing enzymes
12/27/2002	WO2002010379B1 Modified cea and uses thereof
12/27/2002	WO2002005851A8 Enhancement of the action of central and peripheral nervous system agents
12/27/2002	WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer
12/27/2002	WO2001094587A3 Extracellular messengers
12/27/2002	WO2001085141A9 β-GLUCANS ENCAPSULATED IN LIPOSOMES
12/27/2002	WO2001079300A9 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
12/27/2002	WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002	WO2001072123A9 Methods for increasing a cytotoxic t lymphocyte response in vivo
12/27/2002	WO2001058947A9 Lipophilin complexes for use in cancer diagnosis and therapy
12/27/2002	CA2489019A1 Therapeutical vaccination
12/27/2002	CA2456864A1 Adjuvant composition for mucosal and injection delivered vaccines
12/27/2002	CA2455387A1 Fce fusion proteins for treatment of allergy and asthma
12/27/2002	CA2455254A1 Moraxella (branhamella) catarrhalis antigens
12/27/2002	CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002	CA2450730A1 Methods for sterilizing preparations of monoclonal immunoglobulins
12/27/2002	CA2450700A1 Trx1 antibody and uses therefor
12/27/2002	CA2450666A1 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002	CA2450590A1 Methods and compositions for inhibiting, preventing or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002	CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002	CA2448971A1 Chimeric flavivirus vectors
12/27/2002	CA2448506A1 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002	CA2446285A1 Fibroblast growth factor and nucleic acid encoding same
12/27/2002	CA2435151A1 Method for treating psoriasis
12/26/2002	US20020199213 Transgenic transchromosomal rodents for making human antibodies
12/26/2002	US20020198510 Method for nasal application of a medicinal substance
12/26/2002	US20020198509 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
12/26/2002	US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002	US20020198364 Protein for use in controlling reproduction and fertility in humans
12/26/2002	US20020198362 Peptide or polypeptide for use in the diagnosis, prevention and treatment of blood disorders and leukemias
12/26/2002	US20020198168 Vaccine against Mycobacterial infections
12/26/2002	US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same
12/26/2002	US20020198162 A recombinant multivalent antigenic polypeptide containing a first antigenic determinant of a first polypeptide and atleast a second antigenic determinant from a second polypeptide
12/26/2002	US20020198144 MHC molecule that contains a peptide-binding groove, and a presenting peptide covalently linked to the MHC molecule, the fusion complex being capable of modulating the activity of a T cell.
12/26/2002	US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression
12/26/2002	US20020197711 Coxsackievirus B4 expression vectors and uses thereof
12/26/2002	US20020197705 Mutant cells; for propagation of influenza virus mutants
12/26/2002	US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
12/26/2002	US20020197672 Comparative ligand mapping from MHC positive cells
12/26/2002	US20020197670 Membrane associated progesterone receptor
12/26/2002	US20020197668 Papilloma virus capsomere vaccine formulations and methods of use
12/26/2002	US20020197667 Polypeptide for use in the treatment of thrombosis and sepsis
12/26/2002	US20020197657 Apoptosis-related compounds and their use
12/26/2002	US20020197602 Nucleic acid sequences and proteins associated with aging
12/26/2002	US20020197599 Novel adjuvants and copolymer compositions
12/26/2002	US20020197279 Methods for treating tension headache
12/26/2002	US20020197276 Heterologous protection induced by immunization with invaplex vaccine
12/26/2002	US20020197272 Methods for protecting against lethal infection with bacillus anthracis
12/26/2002	US20020197270 Immunogenic compositions for induction of anti-tumor immunity
12/26/2002	US20020197269 Pharmaceutical composition for immunomodulation and preparation of vaccines
12/26/2002	US20020197268 Allergen-containing milk for allergy treatment
12/26/2002	US20020197266 Immunotherapy using interleukin 13 receptor subunit alpha 2
12/26/2002	US20020197265 Methods and compounds for the treatment of immunologically - mediated diseases of the respiratory system using mycobacterium vaccae
12/26/2002	US20020197264 Protecting against canine oral papillomavirus (COPV)
12/26/2002	US20020197263 Novel compounds
12/26/2002	US20020197260 Molecular mimetics of unique neisseria meningitidis serogroup B epitopes
12/26/2002	US20020197259 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers
12/26/2002	US20020197256 Combination therapy
12/26/2002	US20020197255 Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
12/26/2002	US20020197248 Method for treating a LFA-1-mediated disorder
12/26/2002	US20020197243 Novel p53BP2 compounds for therapy and diagnosis and methods for using same
12/26/2002	US20020197236 Treatment of deseases by site specific instillation of cells or sitespecific transformation of cells and kits therefor
12/26/2002	US20020197233 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
12/26/2002	US20020197210 Stabilized therapeutic and imaging agents
12/26/2002	US20020196522 Compliant mechanism and method of forming same
12/25/2002	CN1387571A Mammalian cytokines, related reagents and methods
12/25/2002	CN1387539A Human monoclonal antibodies to prostate specific membrane antigen
12/25/2002	CN1387538A Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
12/25/2002	CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein
12/25/2002	CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002	CN1387443A 联合疫苗组合物 Combined vaccine composition
12/25/2002	CN1387442A Oral recombinant lactobacilli vaccines
12/25/2002	CN1096855C Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof
12/25/2002	CN1096851C Adjuvant for vaccine compsoition
12/24/2002	US6498236 Hybridoma cell culture supernatants, animal plasma or sera, or colostrum. the method includes the use of a minimum of salts, such as lyotropic salts, in the binding process and preferably also the use of small amounts of organic solvents in the
12/24/2002	US6498234 Compounds
12/24/2002	US6498181 Enhancing humoral immune response in combination with cancer therapy including surgery, radiation and immunotherapy
12/24/2002	US6498150 Low molecular weight cell, bone marrow and immune stimulants
12/24/2002	US6498148 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
12/24/2002	US6498021 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-8 and uses thereof
12/24/2002	US6498015 Genetic engineering; production of macrophage derived chemokine; drug screening for antiinflammatory agents
12/24/2002	US6498008 Method for detecting swine infertility and respiratory virus
12/24/2002	US6498006 Administering mixture of liposome and drug
12/24/2002	US6497884 Viable chimeric recombinant flavivirus comprising region of nucleic acid encoding premembrane and envelope structural proteins of langat virus linked to region of nucleic acid encoding non-structural proteins of dengue type 4 virus
12/24/2002	US6497883 Porcine circovirus recombinant poxvirus vaccine
12/24/2002	US6497882 Virus comprising foreign dna inserted into swinepox virus genome within specified region, which is capable of being expressed in host cell into which virus is introduced
12/24/2002	US6497881 Complex comprising streptavidin-protein a fusion protein having antibody and biotin binding sites, bound antibody specific for cell surface protein, which undergoes endocytosis after binding, bound biotinylated toxin, expressed in cell

1 ... 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 ... 1823